middle.news
How Noxopharm’s Sofra™ Platform Boosted BioRay’s Autoimmune Drug Performance
11:31am on Wednesday 11th of June, 2025 AEST
•
Biotechnology
Read Story
How Noxopharm’s Sofra™ Platform Boosted BioRay’s Autoimmune Drug Performance
11:31am on Wednesday 11th of June, 2025 AEST
Key Points
BioRay Pharmaceutical confirms targeted anti-inflammatory activity of Sofra™ oligonucleotides
Successful conjugation of Noxopharm’s oligos enhances BioRay’s antibody drug performance
Material Transfer Agreement with BioRay marks a key international collaboration
Results validate the robustness and versatility of the Sofra™ technology platform
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
NOX
OPEN ARTICLE